To determine whether variations in fluid treatment protocols affect acute neurological outcomes of DKA and long-term neurocognitive function. This was accomplished by evaluating the effects that variations in intravenous fluids (IV) administration rates and sodium content had upon the frequency of mental status abnormalities and cerebral edema symptoms during DKA treatment and upon neurocognitive outcomes 3 months after discharge.
Request Form
Execution of the Agreement:
By entering the required information below and clicking “Agree”, the RECIPIENT certifies their agreement to adhere to the principles, policies and procedures for use of the Data Set as articulated in this Agreement.